Technology and Health Leaders Join Myriad Genetics, Advance in Senior Roles to Drive Key Enterprise Functions, Transformation and Growth Initiatives

NEXT STORY
Junshi Biosciences Announces Acceptance by the NMPA of Supplemental New Drug Application for Toripalimab Combined with Chemotherapy for The First-Line Treatment of Nasopharyngeal Carcinoma
PREV STORY
Ascendis Pharma A/S Announces Participation at SVB Leerink 10th Annual Global Healthcare Conference
Subscribe to PM360
Print Subscription

Experts on Call

Follow Us
Get in touch with PM360 Experts On Call

Ads

You May Also Like

Oncobiologics to Present at the World Biosimilar Congress 2017

CRANBURY, N.J., May 09, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS), a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News

Enzymotec Ltd. Reports Third Quarter 2015 Results

Earns non-GAAP $0.08 and GAAP $0.07 per Diluted Share and Generates $4.7 Million in ...

author_avatar
NASDAQ Market News

Pascal Biosciences and the University of Washington Enter Into Exclusive License Agreement to Develop Cannabinoid-based Medicine for Cancer

Program Developed in Lab of Renowned Cannabis Researcher Dr. Nephi Stella-Lead Candidate for Glioblastoma ...

author_avatar
NASDAQ Market News